Inuvo Bilan de santé
Santé financière contrôle des critères 3/6
Inuvo possède un total de capitaux propres de $12.2M et une dette totale de $2.1M, ce qui porte son ratio d'endettement à 17.7%. Son actif total et son passif total sont $23.2M et de $11.1M.
Informations clés
17.67%
Ratio d'endettement
US$2.15m
Dette
| Ratio de couverture des intérêts | n/a |
| Argent liquide | US$2.89m |
| Fonds propres | US$12.16m |
| Total du passif | US$11.08m |
| Total des actifs | US$23.24m |
Mises à jour récentes de la santé financière
Recent updates
INUV: AI Media Integration Will Shape Future Upside Potential
Analysts have trimmed their price target on Inuvo by $0.05 to $4.20, citing updated views on revenue growth, profit margins, and a lower assumed future P/E multiple as key drivers of the change. Analyst Commentary Recent research updates present a mixed picture for Inuvo, with one firm trimming its price target and another initiating coverage with a more constructive stance.
Inuvo, Inc. – AI-Powered Programmatic Advertising Integration with FreeWheel
Transaction Overview Inuvo, Inc. (“Inuvo” or “the Company”) has announced a strategic integration with FreeWheel to enhance programmatic media buying through artificial intelligence.
INUV: AI Privacy Focus And New CEO Transition Will Support Future Upside
Analysts have reduced their average price target on Inuvo by $4, reflecting updated views on discount rates, long term profit margins and future P/E assumptions, while keeping fair value estimates broadly steady. Analyst Commentary Recent research on Inuvo reflects a mix of optimism on long term growth potential and caution around execution risk and valuation assumptions.INUV: AI Privacy Focus And New CEO Will Drive Future Upside
Analysts have cut their price target on Inuvo by about $5.59 to roughly $5.29, citing updated views on fair value, revenue growth assumptions, and profitability expectations. Analyst Commentary Recent research on Inuvo reflects a mix of optimism on long term potential and caution around execution and valuation, resulting in lower price targets even as some coverage begins with a positive tone.INUV: Rebased Outlook And Leadership Change Will Shape Future Upside Potential
Analysts have reduced Inuvo’s fair value estimate from $6.00 to $4.25. This change reflects updated assumptions around revenue growth, profit margins, discount rates and a lower future P/E that are aligned with recent price target revisions on the stock.
INUV: Execution On New Guidance And Leadership Shift Will Drive Rerating
Analysts lowered their price target on Inuvo by $4 to $11.50, citing more cautious assumptions on revenue growth, profit margins, and a higher forward P/E multiple. Their long-term fair value estimate remained unchanged at $11.50.INUV: Rebased Growth Outlook Will Shape Future Upside Under New Leadership
Analysts have reduced their price target on Inuvo by $4 to reflect updated assumptions for fair value, revenue growth, profit margins, discount rates, and a higher future P/E, as highlighted in recent Street research updates. Analyst Commentary Recent Street research around Inuvo reflects a mixed backdrop, with some firms trimming price targets while others are starting coverage with a constructive stance.INUV: Reduced Marketing Spend In Q3 Will Set Up Q4 Improvement
Analysts trimmed their fair value estimate for Inuvo from US$12.00 to US$11.50 as they factor in slower recent revenue growth and slightly lower profit margin expectations, which are partially offset by a higher assumed future P/E multiple and a modestly higher discount rate. Analyst Commentary Recent research points to a more cautious stance on Inuvo, but there are still clear areas where bullish analysts see room for upside.INUV: Lower Marketing Spend In Q3 Expected To Set Up Q4 Rebound
Analysts have reduced their 12 month price target on Inuvo to US$10 from US$15, citing slower Q3 revenue growth tied to lower marketing spend, while also indicating expectations for a more favorable growth setup into Q4. Analyst Commentary Bullish analysts are framing the price target cut to US$10 as more of a reset than a negative call, pointing out that the move largely reflects the impact of lower Q3 marketing spend rather than a shift in their longer term view of the business.INUV: Q4 Marketing Reacceleration Will Be Key To Renewed Upside
Analysts have trimmed their price target on Inuvo to US$10 from US$15, citing slower Q3 revenue growth tied to reduced marketing spend, while expecting the company's growth outlook to improve in Q4. Analyst Commentary Bullish Takeaways Bullish analysts see the lower Q3 marketing spend as a temporary headwind rather than a structural issue, which they factor into a more moderate price target of US$10.INUV: Fourth Quarter Outlook Expected To Support Bullish Rebound Narrative
Analysts have reduced their price target on Inuvo from $15.00 to $10.00 per share, citing the recent slowdown in revenue growth tied to lower marketing spend, while still expecting a more favorable growth outlook in the fourth quarter. Analyst Commentary Bullish analysts acknowledge the near term impact of reduced marketing spend on Inuvo's third quarter revenue, but emphasize that the underlying demand environment for the company’s technology remains intact.INUV: Future Upside Will Depend On Q4 Marketing Reacceleration
Analysts have reduced their price target on Inuvo to $10 from $15, citing a temporary slowdown in revenue growth from lower marketing spend. They expect the company’s growth outlook to improve in Q4.INUV: Revenue Upside Is Expected As Marketing Plans Are Optimized
Narrative Update on Inuvo: Analyst Price Target Adjustment Analysts have lowered their price target for Inuvo from $15 to $10 following a slowdown in revenue growth last quarter and a continued reassessment of the company's forward outlook. Analyst Commentary Following the recent adjustment in Inuvo's price target, analysts have shared both optimistic perspectives and ongoing concerns regarding the company's valuation and growth outlook.INUV: Revenue Momentum Is Expected To Rebound On Higher Marketing Spend
Analysts have lowered Inuvo's price target by $1.25 to $10.88, citing recent slowing in revenue growth. They also note expectations for improved performance in the coming quarter.Privacy First AI Targeting Will Open Digital Advertising Markets
As both Inuvo’s net profit margin and future P/E multiple remained effectively stable, analysts left the consensus price target unchanged at $12.12. What's in the News Inuvo reaffirmed earnings guidance, expecting at least 25% year-over-year revenue growth for Q2 2025.Automation, AI And Self Serve Platform Will Drive Efficiency
Strong demand and growth in Inuvo’s products and technological advancements in AI and automation are expected to drive revenue and efficiency improvements.Analyse de la situation financière
Passif à court terme: Les actifs à court terme de INUV ( $7.8M ) ne couvrent pas ses passifs à court terme ( $10.6M ).
Passif à long terme: Les actifs à court terme de INUV ( $7.8M ) dépassent ses passifs à long terme ( $497.7K ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: INUV dispose de plus de liquidités que de sa dette totale.
Réduire la dette: Le ratio d'endettement de INUV est passé de 0% à 17.7% au cours des 5 dernières années.
Bilan
Analyse des pistes de trésorerie
Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.
Piste de trésorerie stable: INUV dispose de moins d'un an de piste de trésorerie sur la base de son flux de trésorerie disponible actuel.
Prévisions de trésorerie: INUV dispose d'une marge de trésorerie suffisante pour 1.5 ans si le flux de trésorerie disponible continue de croître à un taux historique de 20.7 % chaque année.
Découvrir des entreprises saines
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/21 07:10 |
| Cours de l'action en fin de journée | 2026/05/21 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Inuvo, Inc. est couverte par 9 analystes. 4 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Brian Kinstlinger | Alliance Global Partners |
| Eric Martinuzzi | Craig-Hallum Capital Group LLC |
| Almas Almaganbetov | Freedom Broker |